After more than 20 years penicillin remains the drug of first choice in the treatment of gonorrhoea. It offers a high cure rate. Curative dosages can be given in one injection in uncomplicated cases. It is relatively safe and it is cheap. On the other hand an increasing number of persons are found to be sensitive to penicillin and, with the increasing incidence of early syphilis, there is again the risk of masking concomitant or incubating forms of that infection. Furthermore, over the years a spiral of events can be discerned in alternating increasing failure rates and larger standard dosages. Thus, whereas 300,000 units of a moderately long-acting form of penicillin sufficed 20 years ago, schedules of 1 2 or 1 8 mega units are now commonplace and multiple dosage is employed by some. The fear that the days of penicillin may be numbered in gonorrhoea therapy has led to trials of a wide range of antibiotics. Such drug trials are essential, not only to establish the best second choice but to show which of the many therapies available may perhaps be tomorrow's first choice.
Modifications of the basic tetracycline molecule has led to a variety of tetracyclines. This study is concerned with one of these, 6-methylene oxytetracycline, known also as methacycline. It is active against a wide range of Gram-positive and Gramnegative organisms, and is said to be more active against some organisms than tetracycline both in vitro and in vivo (Te-wen Chang and Weinstein, 1962) . In vivo studies by Kunin (1962) The range of sensitivity to penicillin (23 cases) and methacycline (5 cases) is shown in Table III . Strains with a penicillin M.I.C. of 0 125 units/ml. or more are generally accepted as relatively insensitive. There were three such strains in this range. None of these strains occurred in men who failed to respond to treatment with methacycline.
There was no correlation between penicillin and methacycline sensitivity levels. The number available in each group, however, is small. Only one of the three cases of failure had a methacycline sensitivity determination (Table ilL) .
Regimen B
There was response in 22 cases. Three men failed to respond but these were cured by current routine dosages of penicillin, i.e. 1 -2 mega units of an aqueous procaine preparation.
Of the 25 men who attended for follow-up Judged by current clinical results, therefore, methacycline therapy in the dosages reported appears as a modest second best.
The trial series included only 12 per cent. less sensitive gonococci as judged by penicillin sensitivity levels. If such levels can be taken as a standard, the results found in the present series must be the most favourable which can be expected.
It is appreciated that lack of national or international standardization of sensitivity testing makes attempts at a dogmatic statement or firm recommendations unwise. We suggest, however, that it would be useful in future drug trials of penicillin or other antibiotics for workers to state at least the sensitivity to penicillin and other antibiotics of the strains under study, as well as the methods employed for such testing. Summary The need to test recently discovered antibiotics in gonorrhoea is indicated by the waning efficacy, even if marginal, of penicillin. A trial of methacycline in two dosage schedules is reported.
The response rates under two regimens, which were almost identical, averaged 87 7 per cent.
The suggestion is made that, in spite of the lack of standardization of sensitivity testing, future trials of any antibiotics in any dosage should, for purposes of comparison, be accompanied by data on the range of sensitivity to penicillin and other antibiotics of the strains under study.
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Usage de la methacycline (Rondomycine) dans le traitement de la blennorragie REsuME La necessite de tester les antibiotiques recemment decouverts pour le traitement de la blennorragie est indiquee A cause de 1'efficacite de la penicilline qui va en diminuant, meme si cette efficacite est marginale. Un essai A deux dosages de methacycline est rapporte.
Les taux de reponses dans les deux dosages ont et presque identiques, de 87,7 pour cent en moyenne.
La suggestion est faite, malgre qu'il n'y ait pas de standardisation pour la sensibilite des tests, que les futurs essais de n'importe quel antibiotique a n'importe quel A single dose of 150 mg. methacycline gives serum levels between 0 39 and 3-12 eug./ml. Higher levels of plasma binding probably exist.
Although the methacycline sensitivity levels of the 49 strains showed a Gaussian distribution similar to the penicillin sensitivity levels of the strains, there was no consistent correlation between methacycline sensitivity and penicillin sensitivity of individual strains. 
